Click on image to view larger version.

Figure 1 Use of reperfusion therapy in all patients and in those presenting with ST segment elevation or LBBB within 12 h of symptom onset. A, A total of 1,514,292 patients were enrolled in NRMI 1, 2 and 3. B, A total of 376,753 patients in NRMI 2 and 3 presented with ST segment elevation or LBBB within 12 h of symptom onset. Either = either IV lytic or primary PTCA; IV lytic = intravenous thrombolytic therapy.